Price target
91.740.000.00%
The 25 analysts offering 1 year price forecasts for 1BMRN have a max estimate of — and a min estimate of —.
Analyst rating
Based on 29 analysts giving stock ratings to 1BMRN in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
1BMRN EPS for the last quarter is 0.49 EUR despite the estimation of 0.48 EUR. In the next quarter EPS is expected to reach 0.53 EUR. Track more of BIOMARIN PHARMACEUTICAL financials and stay on top of what is up with the company.
In the next quarter BIOMARIN PHARMACEUTICAL revenue is expected to reach 686.56 M EUR. Check out BIOMARIN PHARMACEUTICAL revenue and earnings and make informed decisions.
According to analysts, 1BMRN price target is 91.74 EUR with a max estimate of 121.06 EUR and a min estimate of 61.96 EUR. Check if this forecast comes true in a year, meanwhile watch BIOMARIN PHARMACEUTICAL stock price chart and keep track of the current situation with 1BMRN news and stock market news.
We've gathered opinions of 29 analysts rating 1BMRN stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.